Diamonds and Dogs
10/10/14Exact Sciences Corporation (EXAS)
Exact Sciences is looking great today, up 35.76% to $24.60. The molecular diagnostics company saw its shares pop after Medicare officials recommended a $502 reimbursement for Exact Sciences colon cancer screening test. Colonguard is a non-invasive colon cancer screening test and was expected to see a reimbursement of $100-$500, so the news of $502 is above expectations. Shares of Exact Sciences climbed nearly $6.50 today and reached a new 52-week high of $26.79.
Procera Networks Inc. (PKT)
Procera Networks is seeing red today, down 33.33% to $5.70. The intelligent policy enforcement company saw its shares crash after releasing preliminary earnings. For the third quarter, management announced it expects revenue of $16 million which is a 25% decrease year over year. Furthermore, the company expects its full year revenue to be $70-75 million. Both numbers missed analysts' estimates $22.64 million and $85.16 million respectively. Shares of Procera fell to a new 52-week low of $5.61 intraday.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.